Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 9.8a
Adjusted Graft Survival, Deceased Donor Liver Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
11,192
91.7%
0.3%
11,192
85.3%
0.3%
33,183
68.4%
0.3%
55,317
54.4%
0.3%
Primary Diagnosis
Non-Cholestatic Cirrhosis
6,437
92.4%
0.3%
6,437
85.5%
0.5%
19,555
68.3%
0.4%
33,773
52.7%
0.4%
Cholestatic Liver Disease/Cirrhosis
941
91.8%
0.9%
941
87.6%
1.1%
2,897
75.2%
0.9%
5,339
62.5%
0.9%
Acute Hepatic Necrosis
655
87.3%
1.4%
655
82.5%
1.6%
2,196
66.9%
1.2%
4,054
52.1%
1.1%
Biliary Atresia
352
87.5%
2.3%
352
85.1%
2.6%
1,025
76.2%
1.9%
1,911
68.7%
1.6%
Metabolic Diseases
325
90.6%
1.7%
325
85.4%
2.0%
1,057
73.8%
1.6%
1,801
65.8%
1.5%
Malignant Neoplasms
1,891
93.6%
0.6%
1,891
86.3%
0.8%
4,204
64.4%
1.0%
4,943
49.8%
1.8%
Other
591
85.0%
1.5%
591
77.9%
1.8%
2,249
62.6%
1.2%
3,496
52.0%
1.3%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Graft survival follows individual transplants until graft failure.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on liver transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.